| Vol. 17.45 – 15 November, 2023 |
| |
|
|
| A comparative analysis of transcriptomic datasets associated with neuronal regenerative ability revealed circadian rhythms as the most significantly enriched pathway. [Cell Metabolism] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| In a human cortical organoid model of SYNGAP1 haploinsufficiency, researchers found dysregulated cytoskeletal dynamics that impaired the scaffolding and division plane of human radial glia cells. [Nature Neuroscience] |
|
|
|
| The authors employed chemogenetic manipulation of microglia using the artificial Gi-Dreadd receptor within a kainic acid induced murine seizure model. [Brain Behavior And Immunity] |
|
|
|
| Investigators showed that loss of USP30 in Usp30 knockout mice protected against behavioral deficits and led to increased mitophagy, decreased phospho-S129 α-synuclein (αSyn), and attenuation of SN dopaminergic neuronal loss induced by αSyn. [Nature Communications] |
|
|
|
| The authors performed a large-scale activity-dependent phosphoproteome analysis of hippocampal neurons in vitro and identified Tau as a highly phosphorylated and disordered candidate protein. [Nature Communications] |
|
|
|
| Investigators clarified the molecular mechanism of ARL6IP1 in hereditary spastic paraplegia using in vitro and in vivo models. [Journal of Experimental Medicine] |
|
|
|
| Researchers described a human cerebral organoid model of bipolar disorder that exhibited altered neural development, elevated neural network activity, and a major shift in the transcriptome. [Molecular Psychiatry] |
|
|
|
| Scientists used transcriptomic and chromatin accessibility profiling to define activity-driven responses in rat striatal neurons. [eLife] |
|
|
|
| Investigators discovered that U73122, a phosphoinositide-specific phospholipase C inhibitor, dramatically promoted oligodendrocyte precursor cell-to-oligodendrocyte differentiation and myelin regeneration in the experimental autoimmune encephalomyelitis model. [Acta Pharmacologica Sinica] |
| |
|
|
|
| Scientists cover the current understanding of the molecular mechanisms of cyclic GMP-AMP synthase (cGAS) activation and highlight cGAS-stimulator of interferon genes (STING) signaling in various cell types of central and peripheral nervous systems, such as resident brain immune cells, neurons, and glial cells. [Molecular Neurodegeneration] |
|
|
|
| The authors describe and summarize the current efforts made in the development of peptides and their mimetics to directly engage with alpha-synuclein with the intention of modulating aggregation, and importantly, toxicity. [Molecular Neurodegeneration] |
|
|
|
| Investigators summarize how molecular threats activate STING signaling in the diseased brain and how STING signaling activities in glial and neuronal cells cause neuropathology. [Neuron] |
|
|
|
|
| Memorial Sloan Kettering Cancer Center has announced three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research. [Memorial Sloan Kettering Cancer Center] |
|
|
|
| The Paul G. Allen Frontiers Group announced the launch of the Allen Discovery Center for Neuroimmune Interactions at the Icahn School of Medicine at Mount Sinai. [Allen Institute] |
|
|
|
|
| December 2 – 6, 2023 Boston, Massachusetts, United States |
|
|
|
|
|
| NIH National Cancer Institute – Bethesda, Maryland, United States |
|
|
|
| Armenian Bioinformatics Institute – Yerevan, Armenia |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| Tufts University School of Medicine – Boston, Massachusetts, United States |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
|